These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8582471)

  • 1. Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen.
    Gabard B; Nirnberger G; Schiel H; Mascher H; Kikuta C; Mayer JM
    Eur J Clin Pharmacol; 1995; 48(6):505-11. PubMed ID: 8582471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy and dose-response relationship of dexibuprofen (S(+)-ibuprofen) in patients with osteoarthritis of the hip and comparison with racemic ibuprofen using the WOMAC osteoarthritis index.
    Singer F; Mayrhofer F; Klein G; Hawel R; Kollenz CJ
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):15-24. PubMed ID: 10667832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic comparison of controlled- and immediate-release formulations of dexibuprofen after single and multiple oral doses in fasting healthy male Korean volunteers.
    Noh YH; Lim HS; Cho SH; Ghim JL; Choe S; Jung JA; Kim UJ; Park KM; Jang MJ; Bae KS
    Clin Ther; 2011 Sep; 33(9):1132-41. PubMed ID: 21864907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the pharmacokinetics of ibuprofen arginate versus dexibuprofen in healthy volunteers.
    Sádaba B; Campanero MA; Muñoz-Juarez MJ; Gil-Aldea I; García-Quetglas E; Esteras A; Azanza JR
    Eur J Clin Pharmacol; 2006 Oct; 62(10):849-54. PubMed ID: 16909273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relative Bioavailability of Ibuprofen After Administration With a Novel Soft Chewable Drug Formulation.
    Hattrem MN; Dille MJ; Seternes T; Ege T; Draget KI
    Clin Pharmacol Drug Dev; 2018 Feb; 7(2):168-176. PubMed ID: 28444716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and long-term safety of dexibuprofen [S(+)-ibuprofen]: a short-term efficacy study in patients with osteoarthritis of the hip and a 1-year tolerability study in patients with rheumatic disorders.
    Mayrhofer F
    Clin Rheumatol; 2001 Nov; 20 Suppl 1():S22-9. PubMed ID: 11771571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of percutaneous ibuprofen.
    Kleinbloesem CH; Ouwerkerk M; Spitznagel W; Wilkinson FE; Kaiser RR
    Arzneimittelforschung; 1995 Oct; 45(10):1117-21. PubMed ID: 8595072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate.
    Lötsch J; Muth-Selbach U; Tegeder I; Brune K; Geisslinger G
    Br J Clin Pharmacol; 2001 Oct; 52(4):387-98. PubMed ID: 11678782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of dexibuprofen administered as 200 mg and 400 mg film-coated tablets in healthy volunteers.
    Eller N; Kollenz CJ; Schiel H; Kikuta C; Mascher H
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):414-7. PubMed ID: 9726693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Pharmacokinetics and Safety Studies of Dexibuprofen Injection and a Branded Product Ibuprofen Injection in Healthy Chinese Volunteers.
    Hua W; Zhou W; Su M; Zhang Q; Zong S; Wang M
    Clin Pharmacol Drug Dev; 2023 Sep; 12(9):881-887. PubMed ID: 37140399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence study of two formulations containing 400 mg dexibuprofen in healthy Indian subjects.
    Mandal U; Das A; Agarwal S; Chakraborty U; Nandi U; Chattaraj TK; Pal TK
    Arzneimittelforschung; 2008; 58(7):342-7. PubMed ID: 18751500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects and safety of dexibuprofen compared with ibuprofen in febrile children caused by upper respiratory tract infection.
    Yoon JS; Jeong DC; Oh JW; Lee KY; Lee HS; Koh YY; Kim JT; Kang JH; Lee JS
    Br J Clin Pharmacol; 2008 Dec; 66(6):854-60. PubMed ID: 19032727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of a new effervescent tablet of ibuprofen in healthy volunteers.
    Altomare E; Vendemiale G; Benvenuti C; Andreatta P
    Eur J Clin Pharmacol; 1997; 52(6):505-6. PubMed ID: 9342589
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of ibuprofen from matrix mini-tablets based on a mixture of starch and microcrystalline wax.
    De Brabander C; Vervaet C; Görtz JP; Remon JP; Berlo JA
    Int J Pharm; 2000 Nov; 208(1-2):81-6. PubMed ID: 11203270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An eutomer/distomer ratio near unity does not justify non-enantiospecific assay methods in bioequivalence studies.
    García-Arieta A; Abad-Santos F; Rodríguez-Martínez MA; Varas-Polo Y; Novalbos J; Laparidis N; Gallego-Sandín S; Orfanidis K; Torrado J
    Chirality; 2005 Oct; 17(8):470-5. PubMed ID: 16104026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiral separation of ibuprofen and chiral pharmacokinetics in healthy Chinese volunteers.
    Zheng C; Hao H; Wang G; Sang G; Sun J; Li P; Li J
    Eur J Drug Metab Pharmacokinet; 2008; 33(1):45-51. PubMed ID: 18543584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADIDAC trial: analgesia with dexibuprofen versus ibuprofen in patients suffering from primary dysmenorrhea: a crossover trial.
    Kollenz C; Phleps W; Kaehler ST
    Gynecol Obstet Invest; 2009; 67(1):25-31. PubMed ID: 18824862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations.
    Halsas M; Hietala J; Veski P; Jürjenson H; Marvola M
    Int J Pharm; 1999 Nov; 189(2):179-85. PubMed ID: 10536246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of dexibuprofen formulation with fast onset and prolonged effect.
    Choi Y; Min KA; Kim CK
    Drug Dev Ind Pharm; 2019 Jun; 45(6):895-904. PubMed ID: 30889990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.